Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
118002247 | 11800224 | 7 | F | 20151104 | 20160830 | 20151203 | 20160910 | EXP | JP-AMGEN-JPNCT2015128004 | AMGEN | 79.00 | YR | E | F | Y | 32.40000 | KG | 20160910 | MD | JP | JP |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
118002247 | 11800224 | 1 | PS | panitumumab | PANITUMUMAB | 1 | Intravenous drip | 6 MG/KG, Q2WK | 6 | MG/KG | Y | 125147 | 6 | MG/KG | SOLUTION FOR INJECTION | QOW | |||
118002247 | 11800224 | 2 | SS | panitumumab | PANITUMUMAB | 1 | Intravenous drip | 6 MG/KG, Q2WK | 6 | MG/KG | Y | 125147 | 6 | MG/KG | SOLUTION FOR INJECTION | QOW | |||
118002247 | 11800224 | 3 | SS | panitumumab | PANITUMUMAB | 1 | Intravenous drip | 6 MG/KG, Q2WK | 6 | MG/KG | Y | 125147 | 6 | MG/KG | SOLUTION FOR INJECTION | QOW | |||
118002247 | 11800224 | 4 | SS | panitumumab | PANITUMUMAB | 1 | Intravenous drip | 6 MG/KG, Q2WK | 6 | MG/KG | Y | 125147 | 6 | MG/KG | SOLUTION FOR INJECTION | QOW | |||
118002247 | 11800224 | 5 | SS | panitumumab | PANITUMUMAB | 1 | Intravenous drip | 6 MG/KG, Q2WK | 6 | MG/KG | Y | 125147 | 6 | MG/KG | SOLUTION FOR INJECTION | QOW | |||
118002247 | 11800224 | 6 | SS | panitumumab | PANITUMUMAB | 1 | Intravenous drip | 6 MG/KG, Q2WK | 6 | MG/KG | Y | 125147 | 6 | MG/KG | SOLUTION FOR INJECTION | QOW | |||
118002247 | 11800224 | 7 | SS | panitumumab | PANITUMUMAB | 1 | Intravenous drip | 6 MG/KG, Q2WK | 6 | MG/KG | Y | 125147 | 6 | MG/KG | SOLUTION FOR INJECTION | QOW | |||
118002247 | 11800224 | 8 | SS | 5-FU | FLUOROURACIL | 1 | Intravenous bolus | 2400 MG/M2, Q2WEEKS | 4400 | MG/M2 | U | 0 | 400 | MG/M**2 | QOW | ||||
118002247 | 11800224 | 9 | SS | 5-FU | FLUOROURACIL | 1 | Intravenous drip | 2400 MG/M2, Q2WK | 4400 | MG/M2 | U | 0 | 2400 | MG/M**2 | QOW | ||||
118002247 | 11800224 | 10 | SS | 5-FU | FLUOROURACIL | 1 | Intravenous bolus | 200 MG/M2, Q2WK | 4400 | MG/M2 | U | 0 | 200 | MG/M**2 | QOW | ||||
118002247 | 11800224 | 11 | SS | 5-FU | FLUOROURACIL | 1 | Intravenous drip | 200 MG/M2, Q2WK | 4400 | MG/M2 | U | 0 | 200 | MG/M**2 | QOW | ||||
118002247 | 11800224 | 12 | SS | 5-FU | FLUOROURACIL | 1 | Intravenous bolus | 200 MG/M2, Q2WK | 4400 | MG/M2 | U | 0 | 200 | MG/M**2 | QOW | ||||
118002247 | 11800224 | 13 | SS | 5-FU | FLUOROURACIL | 1 | Intravenous drip | 2000 MG/M2, Q2WK | 4400 | MG/M2 | U | 0 | 2000 | MG/M**2 | QOW | ||||
118002247 | 11800224 | 14 | SS | 5-FU | FLUOROURACIL | 1 | Intravenous drip | 1600 MG/M2, Q2WEEKS | 4400 | MG/M2 | U | 0 | 1600 | MG/M**2 | QOW | ||||
118002247 | 11800224 | 15 | SS | 5-FU | FLUOROURACIL | 1 | Intravenous drip | 1600 MG/M2, Q2WEEKS | 4400 | MG/M2 | U | 0 | 1600 | MG/M**2 | QOW | ||||
118002247 | 11800224 | 16 | SS | 5-FU | FLUOROURACIL | 1 | Intravenous drip | 1600 MG/M2, Q2WEEKS | 4400 | MG/M2 | U | 0 | 1600 | MG/M**2 | QOW | ||||
118002247 | 11800224 | 17 | SS | 5-FU | FLUOROURACIL | 1 | Intravenous drip | 1600 MG/M2, Q2WEEKS | 4400 | MG/M2 | U | 0 | 1600 | MG/M**2 | QOW | ||||
118002247 | 11800224 | 18 | SS | OXALIPLATIN. | OXALIPLATIN | 1 | Intravenous drip | 85 MG/M2, Q2WEEKS | 215 | MG/M2 | U | 0 | 85 | MG/M**2 | QOW | ||||
118002247 | 11800224 | 19 | SS | OXALIPLATIN. | OXALIPLATIN | 1 | Intravenous drip | 65 MG/M2, Q2WEEKS | 215 | MG/M2 | U | 0 | 65 | MG/M**2 | QOW | ||||
118002247 | 11800224 | 20 | SS | OXALIPLATIN. | OXALIPLATIN | 1 | Intravenous drip | 65 MG/M2, Q2WEEKS | 215 | MG/M2 | U | 0 | 65 | MG/M**2 | QOW | ||||
118002247 | 11800224 | 21 | SS | OXALIPLATIN. | OXALIPLATIN | 1 | Intravenous drip | 65 MG/M2, Q2WEEKS | 215 | MG/M2 | U | 0 | 65 | MG/M**2 | QOW | ||||
118002247 | 11800224 | 22 | SS | OXALIPLATIN. | OXALIPLATIN | 1 | Intravenous drip | 65 MG/M2, Q2WEEKS | 215 | MG/M2 | U | 0 | 65 | MG/M**2 | QOW | ||||
118002247 | 11800224 | 23 | SS | OXALIPLATIN. | OXALIPLATIN | 1 | Intravenous drip | 65 MG/M2, Q2WEEKS | 215 | MG/M2 | U | 0 | 65 | MG/M**2 | QOW | ||||
118002247 | 11800224 | 24 | C | CALCIUM LEVOFOLINATE | LEVOLEUCOVORIN CALCIUM | 1 | Intravenous drip | 200 MG/M2, Q2WEEKS | 200 | MG/M2 | U | 0 | 200 | MG/M**2 | QOW | ||||
118002247 | 11800224 | 25 | C | CALCIUM LEVOFOLINATE | LEVOLEUCOVORIN CALCIUM | 1 | Intravenous drip | 200 MG/M2, Q2WEEKS | 200 | MG/M2 | U | 0 | 200 | MG/M**2 | QOW | ||||
118002247 | 11800224 | 26 | C | CALCIUM LEVOFOLINATE | LEVOLEUCOVORIN CALCIUM | 1 | Intravenous drip | 200 MG/M2, Q2WEEKS | 200 | MG/M2 | U | 0 | 200 | MG/M**2 | QOW | ||||
118002247 | 11800224 | 27 | C | CALCIUM LEVOFOLINATE | LEVOLEUCOVORIN CALCIUM | 1 | Intravenous drip | 200 MG/M2, Q2WEEKS | 200 | MG/M2 | U | 0 | 200 | MG/M**2 | QOW | ||||
118002247 | 11800224 | 28 | C | CALCIUM LEVOFOLINATE | LEVOLEUCOVORIN CALCIUM | 1 | Intravenous drip | 200 MG/M2, Q2WEEKS | 200 | MG/M2 | U | 0 | 200 | MG/M**2 | QOW | ||||
118002247 | 11800224 | 29 | C | CALCIUM LEVOFOLINATE | LEVOLEUCOVORIN CALCIUM | 1 | Intravenous drip | 200 MG/M2, Q2WEEKS | 200 | MG/M2 | U | 0 | 200 | MG/M**2 | QOW | ||||
118002247 | 11800224 | 30 | C | CALCIUM LEVOFOLINATE | LEVOLEUCOVORIN CALCIUM | 1 | Intravenous drip | 200 MG/M2, Q2WEEKS | 200 | MG/M2 | U | 0 | 200 | MG/M**2 | QOW | ||||
118002247 | 11800224 | 31 | C | BROTIZOLAM | BROTIZOLAM | 1 | Oral | 0.25 MG, QD | U | 0 | .25 | MG | QD | ||||||
118002247 | 11800224 | 32 | C | BIO-THREE | HERBALS | 1 | Oral | 1 G, TID | U | 0 | 1 | G | TID | ||||||
118002247 | 11800224 | 33 | C | MINOMYCIN | MINOCYCLINE HYDROCHLORIDE | 1 | Oral | 50 MG, BID | U | 0 | 50 | MG | BID | ||||||
118002247 | 11800224 | 34 | C | NOVAMIN | PROCHLORPERAZINE MALEATE | 1 | Oral | 50 MG, UNK | U | 0 | 50 | MG | |||||||
118002247 | 11800224 | 35 | C | HIRUDOID | GLYCOSAMINOGLYCANS | 1 | Transdermal | UNK, BID | U | 0 | BID |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
118002247 | 11800224 | 1 | Colon cancer recurrent |
118002247 | 11800224 | 2 | Metastases to retroperitoneum |
118002247 | 11800224 | 8 | Colon cancer recurrent |
118002247 | 11800224 | 9 | Metastases to retroperitoneum |
118002247 | 11800224 | 18 | Colon cancer recurrent |
118002247 | 11800224 | 19 | Metastases to retroperitoneum |
118002247 | 11800224 | 24 | Colon cancer recurrent |
118002247 | 11800224 | 25 | Metastases to retroperitoneum |
118002247 | 11800224 | 31 | Insomnia |
118002247 | 11800224 | 32 | Gastrointestinal disorder |
118002247 | 11800224 | 33 | Prophylaxis |
118002247 | 11800224 | 34 | Nausea |
118002247 | 11800224 | 35 | Prophylaxis |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
118002247 | 11800224 | OT |
118002247 | 11800224 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
118002247 | 11800224 | Amylase increased | |
118002247 | 11800224 | Anaemia | |
118002247 | 11800224 | Dry skin | |
118002247 | 11800224 | Febrile neutropenia | |
118002247 | 11800224 | Gastrointestinal oedema | |
118002247 | 11800224 | Hyperamylasaemia | |
118002247 | 11800224 | Hyperkalaemia | |
118002247 | 11800224 | Hypoalbuminaemia | |
118002247 | 11800224 | Hypocalcaemia | |
118002247 | 11800224 | Hypomagnesaemia | |
118002247 | 11800224 | Impaired gastric emptying | |
118002247 | 11800224 | Nausea | |
118002247 | 11800224 | Neutrophil count decreased | |
118002247 | 11800224 | Palmar-plantar erythrodysaesthesia syndrome | |
118002247 | 11800224 | Paronychia | |
118002247 | 11800224 | Platelet count decreased | |
118002247 | 11800224 | Pyrexia | |
118002247 | 11800224 | Stomatitis | |
118002247 | 11800224 | White blood cell count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
118002247 | 11800224 | 1 | 20151102 | 20151102 | 0 | |
118002247 | 11800224 | 2 | 20151125 | 20151125 | 0 | |
118002247 | 11800224 | 3 | 20151216 | 20151216 | 0 | |
118002247 | 11800224 | 4 | 20160127 | 20160127 | 0 | |
118002247 | 11800224 | 5 | 20160224 | 20160224 | 0 | |
118002247 | 11800224 | 6 | 20160316 | 20160316 | 0 | |
118002247 | 11800224 | 7 | 20160418 | 20160627 | 0 | |
118002247 | 11800224 | 8 | 20151102 | 20151102 | 0 | |
118002247 | 11800224 | 9 | 20151102 | 20151102 | 0 | |
118002247 | 11800224 | 10 | 20151125 | 20151125 | 0 | |
118002247 | 11800224 | 11 | 20151125 | 20151125 | 0 | |
118002247 | 11800224 | 12 | 20151216 | 20151216 | 0 | |
118002247 | 11800224 | 13 | 20151216 | 20151216 | 0 | |
118002247 | 11800224 | 14 | 20160127 | 20160127 | 0 | |
118002247 | 11800224 | 15 | 20160224 | 20160224 | 0 | |
118002247 | 11800224 | 16 | 20160316 | 20160316 | 0 | |
118002247 | 11800224 | 17 | 20160418 | 20160629 | 0 | |
118002247 | 11800224 | 18 | 20151102 | 20151102 | 0 | |
118002247 | 11800224 | 19 | 20151125 | 20151125 | 0 | |
118002247 | 11800224 | 20 | 20151216 | 20151216 | 0 | |
118002247 | 11800224 | 21 | 20160127 | 20160127 | 0 | |
118002247 | 11800224 | 22 | 20160224 | 20160224 | 0 | |
118002247 | 11800224 | 23 | 20160316 | 20160316 | 0 | |
118002247 | 11800224 | 24 | 20151102 | 20151102 | 0 | |
118002247 | 11800224 | 25 | 20151125 | 20151125 | 0 | |
118002247 | 11800224 | 26 | 20151216 | 20151216 | 0 | |
118002247 | 11800224 | 27 | 20160127 | 20160127 | 0 | |
118002247 | 11800224 | 28 | 20160224 | 20160224 | 0 | |
118002247 | 11800224 | 29 | 20160316 | 20160316 | 0 | |
118002247 | 11800224 | 30 | 20160418 | 20160627 | 0 | |
118002247 | 11800224 | 32 | 20151104 | 0 | ||
118002247 | 11800224 | 33 | 20151028 | 0 | ||
118002247 | 11800224 | 34 | 20151202 | 0 | ||
118002247 | 11800224 | 35 | 20151028 | 0 |